Somayyeh Koohi

Dr. Somayyeh Koohi


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2023 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
MKMahmood Kalemati
Mahmood Kalemati
MEMojtaba Zamani Emani
Mojtaba Zamani Emani
SKSomayyeh Koohi
Somayyeh Koohi
Drug-target binding affinity prediction plays a key role in the early stage of drug discovery. Numerous experimental and data-driven approaches have been developed for predicting drug-target binding affinity. However, experimental methods highly rely on the limited structural-related information from drug-target pairs, domain knowledge, and time-consuming assays. On the other hand, learning-based methods have shown an acceptable prediction performance. However, most of them utilize several simple and complex types of proteins and drug compounds data, ranging from the protein sequences to the topology of a graph representation of drug compounds, employing multiple deep neural networks for encoding and feature extraction, and so, leads to the computational overheads. In this study, we propose a unified measure for protein sequence encoding, named BiComp, which provides compression-based and evolutionary-related features from the protein sequences. Specifically, we employ Normalized Compression Distance and Smith-Waterman measures for capturing complementary information from the algorithmic information theory and biological domains, respectively. We utilize the proposed measure to encode the input proteins feeding a new deep neural network-based method for drug-target binding affinity prediction, named BiComp-DTA. BiComp-DTA is evaluated utilizing four benchmark datasets for drug-target binding affinity prediction. Compared to the state-of-the-art methods, which employ complex models for protein encoding and feature extraction, BiComp-DTA provides superior efficiency in terms of accuracy, runtime, and the number of trainable parameters. The latter achievement facilitates execution of BiComp-DTA on a normal desktop computer in a fast fashion. As a comparative study, we evaluate BiComp’s efficiency against its components for drug-target binding affinity prediction. The results have shown superior accuracy of BiComp due to the orthogonality and complementary nature of Smith-Waterman and Normalized Compression Distance measures for protein sequences. Such a protein sequence encoding provides efficient representation with no need for multiple sources of information, deep domain knowledge, and complex neural networks.

5 May 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
MKMahmood Kalemati
Mahmood Kalemati
Saeid DARVISHISaeid DARVISHI
Saeid DARVISHI
SKSomayyeh Koohi
Somayyeh Koohi
The Major Histocompatibility Complex (MHC) binds to the derived peptides from pathogens to present them to killer T cells on the cell surface. Developing computational methods for accurate, fast, and explainable peptide-MHC binding prediction can facilitate immunotherapies and vaccine development. Various deep learning-based methods rely on separate feature extraction from the peptide and MHC sequences and ignore their pairwise binding information. This paper develops a capsule neural network-based method to efficiently capture the peptide-MHC complex features to predict the peptide-MHC class I binding. Various evaluations confirmed our method outperformance over the alternative methods, while it can provide accurate prediction over less available data. Moreover, for providing precise insights into the results, we explored the essential features that contributed to the prediction. Since the simulation results demonstrated consistency with the experimental studies, we concluded that our method can be utilized for the accurate, rapid, and interpretable peptide-MHC binding prediction to assist biological therapies.

2 May 2023 in BMC Genomics
Verified
Journal Article
Open access
PDF file
SASaeedeh Akbari Rokn Abadi
Saeedeh Akbari Rokn Abadi
SLSeyed Pouria Laghaee
Seyed Pouria Laghaee
SKSomayyeh Koohi
Somayyeh Koohi
Background: It is now possible to analyze cellular heterogeneity at the single-cell level thanks to the rapid developments in single-cell sequencing technologies. The clustering of cells is a fundamental and common step in heterogeneity analysis. Even so, accurate cell clustering remains a challenge due to the high levels of noise, the high dimensions, and the high sparsity of data. Results: Here, we present SCEA, a clustering approach for scRNA-seq data. Using two consecutive units, an encoder based on MLP and a graph attention auto-encoder, to obtain cell embedding and gene embedding, SCEA can simultaneously achieve cell low-dimensional representation and clustering performing various examinations to obtain the optimal value for each parameter, the presented result is in its most optimal form. To evaluate the performance of SCEA, we performed it on several real scRNA-seq datasets for clustering and visualization analysis. Conclusions: The experimental results show that SCEA generally outperforms several popular single-cell analysis methods. As a result of using all available datasets, SCEA, in average, improves clustering accuracy by 4.4% in ARI Parameters over the well-known method scGAC. Also, the accuracy improvement of 11.65% is achieved by SCEA, compared to the Seurat model.

25 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMahmood Kalemati
Mahmood Kalemati
ANAlireza Noroozi
Alireza Noroozi
ASAref Shahbakhsh
Aref Shahbakhsh
SKSomayyeh Koohi
Somayyeh Koohi
Efficiently predicting the paratope holds immense potential for enhancing antibody design, treating cancers and other serious diseases, and advancing personalized medicine. Although traditional methods are highly accurate, they are often time-consuming, labor-intensive, and reliant on 3D structures, restricting their broader use. On the other hand, machine learning-based methods, besides relying on structural data, entail descriptor computation, consideration of diverse physicochemical properties, and feature engineering. Here, we develop a deep learning-assisted prediction method for paratope identification, relying solely on amino acid sequences and being antigen-agnostic. Built on the ProtTrans architecture, and utilizing pre-trained protein and antibody language models, we extract efficient embeddings for predicting paratope. By incorporating positional encoding for Complementarity Determining Regions, our model gains a deeper structural understanding, achieving remarkable performance with a 0.904 ROC AUC, 0.701 F1-score, and 0.585 MCC on benchmark datasets. In addition to yielding accurate antibody paratope predictions, our method exhibits strong performance in predicting nanobody paratope, achieving a ROC AUC of 0.912 and a PR AUC of 0.665 on the nanobody dataset. Notably, our approach outperforms structure-based prediction methods, boasting a PR AUC of 0.731. Various conducted ablation studies, which elaborate on the impact of each part of the model on the prediction task, show that the improvement in prediction performance by applying CDR positional encoding together with CNNs depends on the specific protein and antibody language models used. These results highlight the potential of our method to advance disease understanding and aid in the discovery of new diagnostics and antibody therapies.

14 October 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHoda Sadeghzadeh
Hoda Sadeghzadeh
SKSomayyeh Koohi
Somayyeh Koohi
The classification performance of all-optical Convolutional Neural Networks (CNNs) is greatly influenced by components’ misalignment and translation of input images in the practical applications. In this paper, we propose a free-space all-optical CNN (named Trans-ONN) which accurately classifies translated images in the horizontal, vertical, or diagonal directions. Trans-ONN takes advantages of an optical motion pooling layer which provides the translation invariance property by implementing different optical masks in the Fourier plane for classifying translated test images. Moreover, to enhance the translation invariance property, global average pooling (GAP) is utilized in the Trans-ONN structure, rather than fully connected layers. The comparative studies confirm that taking advantage of vertical and horizontal masks along GAP operation provide the best translation invariance property, compared to the alternative network models, for classifying horizontally and vertically shifted test images up to 50 pixel shifts of Kaggle Cats and Dogs, CIFAR-10, and MNIST datasets, respectively. Also, adopting the diagonal mask along GAP operation achieves the best classification accuracy for classifying translated test images in the diagonal direction for large number of pixel shifts (i.e. more than 30 pixel shifts). It is worth mentioning that the proposed translation invariant networks are capable of classifying the translated test images not included in the training procedure.

9 May 2024 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MKMahmood Kalemati
Mahmood Kalemati
MEMojtaba Zamani Emani
Mojtaba Zamani Emani
SKSomayyeh Koohi
Somayyeh Koohi
Background: In recent years, there has been a growing interest in utilizing computational approaches to predict drug-target binding affinity, aiming to expedite the early drug discovery process. To address the limitations of experimental methods, such as cost and time, several machine learning-based techniques have been developed. However, these methods encounter certain challenges, including the limited availability of training data, reliance on human intervention for feature selection and engineering, and a lack of validation approaches for robust evaluation in real-life applications. Results: To mitigate these limitations, in this study, we propose a method for drug-target binding affinity prediction based on deep convolutional generative adversarial networks. Additionally, we conducted a series of validation experiments and implemented adversarial control experiments using straw models. These experiments serve to demonstrate the robustness and efficacy of our predictive models. We conducted a comprehensive evaluation of our method by comparing it to baselines and state-of-the-art methods. Two recently updated datasets, namely the BindingDB and PDBBind, were used for this purpose. Our findings indicate that our method outperforms the alternative methods in terms of three performance measures when using warm-start data splitting settings. Moreover, when considering physiochemical-based cold-start data splitting settings, our method demonstrates superior predictive performance, particularly in terms of the concordance index. Conclusion: The results of our study affirm the practical value of our method and its superiority over alternative approaches in predicting drug-target binding affinity across multiple validation sets. This highlights the potential of our approach in accelerating drug repurposing efforts, facilitating novel drug discovery, and ultimately enhancing disease treatment. The data and source code for this study were deposited in the GitHub repository, https://github.com/mojtabaze7/DCGAN-DTA. Furthermore, the web server for our method is accessible at https://dcgan.shinyapps.io/bindingaffinity/.